See More Hear More Watch More Hear More Get on iTunes
deletedatc deletedatc

TPP Negotiators - Compromise On Biologics Drugs

A big sticking point in the negotiations over the Trans-Pacific Partnership involved biologics medicines and vaccines created from living organisms. Dispute centered on patent protection: how many years drug companies should have before facing competition from generics. Negotiators ended up with a complicated compromise that gives drug makers 5 to 8 years of protection. More Info: #FullNewsAudioAvailable #NPR


More from